500 Plaza Drive
13 articles with Quest Diagnostics
Quest Diagnostics to Present New Insights from Genetic Testing at the 2018 American Society of Human Genetics Annual Meeting
Four Presentations Reveal Genetic Insights from Quest's Advanced Diagnostics
Bolsters company's expert screening and intervention services for employers and managed populations
Quest Diagnostics Launches the Global Diagnostics Network (GDN) to Improve Healthcare by Increasing Access to Diagnostic Insights Around the World
The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation
As the timeline shortens for Albert Bourla to take over the reins of Pfizer from Chief Executive Officer Ian Read, the company has released details of the new senior management team that will continue to lead the company forward.
Quest Diagnostics Earns Gold Status in National Business Group on Health's Best Employers for Healthy Lifestyles Awards
Quest Diagnostics announced today that it received the Gold Award in the 2018 Best Employers for Healthy Lifestyles awards from the National Business Group on Health (NBGH).
Quest Diagnostics Incorporated announced that it will report third quarter 2018 results on Tuesday, October 23, 2018, before the market opens.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement to sell its India medical diagnostics business to Strand Life Sciences, a Bangalore-based specialized diagnostics company.
PhenoPath deepens Quest's presence in the Pacific Northwest while extending the company's capabilities in anatomic pathology and molecular oncology
Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United States.
Bolsters Quest's leadership in advanced diagnostics for women's and reproductive health
Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record of Quest Diagnostics common stock on October 5, 2018.
New Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing and is Now Present in New U.S. States
Number of positive tests for Lyme disease increased significantly between 2016 and 2017
Third annual study from Quest Diagnostics of health plan executives and physicians suggests physicians need better tools, data access and less complex quality measures to spur adoption